5[1]Wallace H,Shorvon S,Tallis R.Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2 052 922 and age-specific fertility rates of women with epilepsy[J]. Lancet , 1998,352(19/26):1970.
6[2]Zahn C. Neurologic care of pregnant woman with epilepsy[J]. Epilepsia, 1998,39 (Suppl 8):S26.
7[3]Samren EB, Cornelia MVD, Chritiaens GCML, et al .Antiepileptic drug regimens and major congenital abnormalities in the offspring[J]. Ann Neurol, 1997,46(5):739.
8[4]Carla A, Sonia B, Elisapeth R, et al. Teratogenic effects of antiepileptic drugs: use of an international database on malformations and Drug Exposure(MADRE)[J]. Epilepsia, 2000,41(11):1436.
9[5]Wlodarczyk B, Biernacki B, Minta M. Teratogenic action of antiepileptic drug: 2-propylpentanoicacid effects on rat and hamster embryos caltured in vitro[J]. Ginekol Pol, 2001,72(12):955.
10[6]Stoler JM. Maternal antiepileptic drug use and effects on fetal development[J]. Curr Opin Pediatr, 2001, 13(6):566.
2Verrotti A, Agostinelli S, Coppola G, et al. A 12 - month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy [ J ]. Eur J Neurol,2010,17 ( 2 ) :232 - 237.
3Krishnamoorthy G , Karande S, Ahire N ,et al. Bone metabolism alteration on antiepileptic drug therapy[ J ]. Indian J Pediatr, 2009,76 (4) : 377 - 383.
4Rauchenzauner M, Griesmacher A, Tatarczyk T, et al. Chronic antiepileptic monotherapy,bone metabolism, and body composition in non - institutionalized children[ J ]. Dev Med Child Neurol, 2009,52 ( 3 ) : 283 - 288.
5Ferin M, Morrell M, Xiao E,et al. Endocrine and metabolic responses to long - term monotherapy with the antiepileptic drug valproate in thenormally cycling rhesus monkey [ J ]. J Clin Endocrinol Metab, 2003,88 (6) :2908 -2915.
6Nakken KO,Tauboll E. Bone loss associated with use of antiepileptic drugs[J].Expert Opin Drug Saf,2010,9(4) :1 - 11.
7Fuleihan G, Nabulsi M,Tamin H, et al. Effect of vitamin D replacement on musculoskelctal parameters in school children:A randomized controlled trial [ J]. J Clin Endocrinol Metab ,2006,91 ( 2 ) :405 - 412.
8Mikati MA, Dib L,Yamout B,et al. Two randomized vitamin D trials in ambulatory patients on anticonvulsants[J]. Neurology,2006,67 ( 11 ) : 2005 - 2014.
9Phabphal K, Geater A, Leelawattana R, et al. Prevalence and risk fac- tors of low bone mineral density and 25 - hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug [ J ]. Bone, 2009,45 ( 2 ) : 232 - 237.
10Kay SR. Profiles of aggresion among psychiatric patients[J]. J Netv Ment Dis, 1988,176(9) :546.
